Securing sustained funding for ambitious clinical programs requires more than strong science, it requires credible delivery architecture that aligns diverse stakeholders and funding sources.
This work addressed a recurring problem in medical research: strong science failing to secure sustained funding because delivery structures were not yet credible.
I co-designed a funding and collaboration model that aligned government, philanthropic, and institutional investment, creating the conditions for durable clinical trial infrastructure.
This thinking was published as a peer-reviewed Perspective in the Medical Journal of Australia and helped lay the groundwork for a $14 million national paediatric brain cancer clinical trials consortium.